Stay updated on OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Many new recruitment sites were added across the US, Argentina, Australia, and numerous European and Asian countries, expanding the geographic availability of study sites. At the same time, a large number of existing locations were removed.
    Difference
    4%
    Check dated 2025-12-23T21:05:31.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-25T11:28:50.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Removed the general operations notice about government funding; this is a minor change that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-18T07:12:52.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Updated the trial site location name from Tainan City to Tainan (Taiwan, 736) in the Locations section.
    Difference
    0.0%
    Check dated 2025-11-11T02:54:01.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Removed external health information links (MedlinePlus Genetics, MedlinePlus breast cancer, DailyMed, NIH/NIH.gov, and related resources) from the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:14:15.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Added external information links to MedlinePlus genetics and breast cancer pages, DailyMed drug information for the therapies listed in the study, Olema publications, and U.S. government sites. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-27T19:15:26.000Z thumbnail image

Stay in the know with updates to OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.